TXNIP and infarction: As shown in Fig. 7C and D, myocardial injury in Txnip siRNA-treated hearts was markedly alleviated compared with vehicle or scrambled siRNA-injected hearts, as evidenced by decreased myocardial infarct size and caspase-3 activity (P < 0.05).